RE:RE:share price manipulation at its finest!Who stands to gain by keeping this stock, which has such potential, so low for so long, I don't believe it is algorithmic trading (HFT).
It doesn't need boiler rooms just a few dedicated well paid folks. So who is paying them?
How many small biotechs have been bought up recently for fairly massive amounts $wise. Most behind us in their research but some perhaps ahead when it comes to let's say lung or glioblastoma. One thing they do have in common is multi very expensive, in some cases, never ending treatments.
What is the potential in treatments with TLT? One, two, maybe even three.
Think of the billions invested in other cash cow treatments right across the pharmaceutical spectrum. Even with a successful TLT could a successful pharma ever recoup its losses from its other treatments, and that's the successful one, what about the others?
I could go on, but I think I'll put my paranoia to bed for now. :-)